Abstinence Duration for Male Infertility
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a very short period of abstinence, just one hour, can increase the likelihood of producing embryos with normal chromosomes during IVF. Researchers will compare this ultrashort abstinence with the standard 2-5 days of abstinence to determine which is more effective. Women undergoing IVF who have retrieved a good number of eggs may be suitable candidates. The trial focuses on participants using fresh sperm samples and not using donor eggs or sperm. As an unphased trial, this study provides a unique opportunity to contribute to groundbreaking research that could improve IVF success rates.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this protocol is safe for improving embryo chromosomal normalcy in IVF?
Research has shown that shorter breaks between ejaculations can affect sperm quality. Some studies suggest that shorter intervals might improve sperm motility and reduce DNA damage, which could benefit men facing infertility issues. However, other reports indicate that very short breaks, such as four hours, might result in less semen and fewer sperm compared to longer breaks of two to seven days.
Overall, shorter breaks might enhance some aspects of sperm quality but could weaken others. Discussing this approach with a doctor is important to determine its suitability.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how different durations of abstinence affect male infertility treatment outcomes. Unlike traditional methods that recommend 2-5 days of abstinence before sperm collection, the trial is investigating the effects of ultrashort abstinence, which involves only one hour of abstinence. This approach could offer quicker and potentially more efficient fertility solutions. By understanding the impact of varying abstinence periods, this research could lead to optimized protocols for male infertility, potentially improving success rates for conception.
What evidence suggests that this trial's treatments could be effective for improving embryo chromosomal normalcy in IVF?
This trial will compare the effects of ultrashort abstinence with standard abstinence on sperm quality. Research has shown that a shorter time without ejaculation can improve sperm quality. Specifically, studies found that sperm collected after just 1 hour of abstinence, as tested in the ultrashort abstinence arm of this trial, had a higher total sperm count and moved better compared to longer periods without ejaculation. Shorter abstinence times might also reduce sperm damage, potentially leading to healthier embryos. This suggests that very short abstinence could be a promising method to improve embryo quality during IVF.23678
Are You a Good Fit for This Trial?
This trial is for individuals or couples dealing with infertility issues, specifically male infertility. Participants should be undergoing in vitro fertilization (IVF) treatment and willing to produce sperm after either an ultrashort period of abstinence (1 hour) or adhere to the standard abstinence guidelines.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
IVF Treatment
Participants undergo IVF treatment with eggs exposed to sperm after ultrashort and standard abstinence periods
Embryo Transfer
Transfer of euploid embryos back into participants
Follow-up
Participants are monitored for pregnancy rates and embryo development outcomes
Long-term Follow-up
Assessment of sperm DNA fragmentation and DNA methylation results
What Are the Treatments Tested in This Trial?
Interventions
- Standard abstinence
- Ultrashort abstinence
Find a Clinic Near You
Who Is Running the Clinical Trial?
UConn Health
Lead Sponsor
The Center for Advanced Reproductive Services, P.C.
Collaborator